24 research outputs found

    Multiple regression results for the prediction of the response to therapy using imaging features.

    No full text
    <p>Multiple regression results for the prediction of the response to therapy using imaging features.</p

    Comparison of image histogram in different tissues in responders and non-responders.

    No full text
    <p>Average histograms of GM image (left), WM image (middle), and CSF image (right) for non-responders (top row) and responders (bottom row).</p

    Three different cases of neighborhood between Gd-enhanced area and necrosis.

    No full text
    <p>a) Gd-enhanced area is not fully adjacent to necrosis (Patient ID: 969). b) Gd-enhanced area contains necrosis and there is complete adjacency (Patient ID: 852). c) There is no necrosis (Patient ID: 178).</p

    Tumor volumes and treatment effects on the tumors and time lengths between acquisitions as well as survival length.

    No full text
    <p>Tumor volumes before bevacizumab treatment as well as relative changes in the Gd-enhancement, edema, and necrosis, between baseline MRI and the one acquired about 2–3 months after the treatment, calculated by (<i>V</i><sub>1</sub>−<i>V</i><sub>2</sub>)/<i>V</i><sub>1</sub>, length of time between two image acquisitions, and survival times of the patients.</p><p>(*:tumors without necrosis or those with minimal adjacency of Gd-enhanced and necrotic areas).</p

    Comparison of the actual responses and estimates responses using Leave-One-Out method.

    No full text
    <p>Responses estimated using leave-one-out and the five features in the last row of <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0029945#pone-0029945-t005" target="_blank">Table 5</a> (red columns) compared to actual results (blue columns). The relative change in the size of the Gd-enhanced region was used as the measure of response. The horizontal axis shows the patient that has been eliminated in leave-one-out analysis.</p
    corecore